Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Daclizumab discontinue letter for the US market
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
Genzyme's Lemtrada™ Approved in Brazil for Treatment of Multiple Sclerosis
Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis.
Stopping Disease Modifying Therapy in Progressive Multiple Sclerosis - A Prospective Study
Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.
Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™).
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.
Acute pancreatitis: possible association of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis.
The immunopathology of multiple sclerosis: an overview.
GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study.
Gender identity disorders and multiple sclerosis risk: A national record-linkage study.
Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder.
One calcitriol dose transiently increases Helios(+)FoxP3(+) T cells and ameliorates autoimmune demyelinating disease.
Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.
Keystone Symposium: Advances in the Knowledge and Treatment of Autoimmunity
JC Virus in CD34+ and CD19+ Cells in Patients With Multiple Sclerosis Treated With Natalizumab.
Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.
Alemtuzumab
Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-beta1b.
Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor.
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration.
Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies.
Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators.

Pages